PMID- 18768298 OWN - NLM STAT- MEDLINE DCOM- 20081211 LR - 20160526 IS - 0920-9964 (Print) IS - 0920-9964 (Linking) VI - 105 IP - 1-3 DP - 2008 Oct TI - Different psychological effects of cannabis use in adolescents at genetic high risk for schizophrenia and with attention deficit/hyperactivity disorder (ADHD). PG - 216-23 LID - 10.1016/j.schres.2008.07.010 [doi] AB - BACKGROUND: Controversy exists regarding whether young people at risk for schizophrenia are at increased risk of adverse mental effects of cannabis use. METHODS: We examined cannabis use and mental health functioning in three groups of young people aged 14-21; 36 non-psychotic siblings of adolescents with schizophrenia (genetic high risk group), 25 adolescents with attention deficit hyperactivity disorder (ADHD) and 72 healthy controls. The groups were sub-divided into 'users' and 'non-users' of cannabis based on how often they had used cannabis previously. Mental health functioning was quantified by creating a composite index derived from scores on the Schizotypal Personality Questionnaire (SPQ), Strengths and Difficulties Questionnaire (SDQ) and Global Assessment of Function (GAF). RESULTS: A significant positive association between cannabis use and mental health disturbance was confined to young people at genetic high risk for schizophrenia. To determine whether the relationship was specific to particular dimensions of mental health function, a second composite index was created based on scores from the SPQ Disorganisation and SDQ hyperactivity-inattention sub-scales. Again, there was a significant positive association between cannabis use and factor scores which was specific to the genetic high risk group. There was a trend for this association to be negative in the ADHD group (p=0.07). CONCLUSIONS: The findings support the view that young people at genetic high risk for schizophrenia are particularly vulnerable to mental health problems associated with cannabis use. Further research is needed to investigate the basis of relationships between cannabis and mental health in genetically vulnerable individuals. FAU - Hollis, Chris AU - Hollis C AD - Developmental Psychiatry, University of Nottingham, E Floor, South Block, Queens Medical Centre, Derby Road, Nottingham, England NG7 2UH, UK. chris.hollis@nottingham.ac.uk FAU - Groom, Madeleine J AU - Groom MJ FAU - Das, Debasis AU - Das D FAU - Calton, Tim AU - Calton T FAU - Bates, Alan T AU - Bates AT FAU - Andrews, Hayley K AU - Andrews HK FAU - Jackson, Georgina M AU - Jackson GM FAU - Liddle, Peter F AU - Liddle PF LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20080902 PL - Netherlands TA - Schizophr Res JT - Schizophrenia research JID - 8804207 SB - IM MH - Adolescent MH - Adult MH - Attention Deficit Disorder with Hyperactivity/epidemiology/*genetics MH - Cannabis/*adverse effects MH - Cognition Disorders/diagnosis/psychology MH - Control Groups MH - Cross-Sectional Studies MH - Female MH - Genetic Predisposition to Disease/epidemiology/psychology MH - Humans MH - Male MH - Marijuana Abuse/*complications/diagnosis/psychology MH - Neuropsychological Tests MH - Prevalence MH - Psychiatric Status Rating Scales MH - Psychology, Adolescent MH - Risk Factors MH - Schizophrenia/diagnosis/*epidemiology/genetics MH - *Schizophrenic Psychology MH - Severity of Illness Index MH - Surveys and Questionnaires EDAT- 2008/09/05 09:00 MHDA- 2008/12/17 09:00 CRDT- 2008/09/05 09:00 PHST- 2008/03/26 00:00 [received] PHST- 2008/07/04 00:00 [revised] PHST- 2008/07/19 00:00 [accepted] PHST- 2008/09/05 09:00 [pubmed] PHST- 2008/12/17 09:00 [medline] PHST- 2008/09/05 09:00 [entrez] AID - S0920-9964(08)00333-2 [pii] AID - 10.1016/j.schres.2008.07.010 [doi] PST - ppublish SO - Schizophr Res. 2008 Oct;105(1-3):216-23. doi: 10.1016/j.schres.2008.07.010. Epub 2008 Sep 2.